Hypoxia-mediated mitochondria apoptosis inhibition induces temozolomide treatment resistance through miR-26a/Bad/Bax axis
Open Access
- 13 November 2018
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 9 (11) , 1-16
Abstract
Glioblastoma multiforme (GBM) is one of the most hypoxic tumors of the central nervous system. Although temozolomide (TMZ) is an effective clinical agent in the GBM therapy, the hypoxic microenvironment remains a major barrier in glioma chemotherapy resistance, and the underlying mechanisms are poorly understood. Here, we find hypoxia can induce the protective response to mitochondrion via HIF-1α-mediated miR-26a upregulation which is associated with TMZ resistance in vitro and in vivo. Further, we demonstrated that HIF-1α/miR-26a axis strengthened the acquisition of TMZ resistance through prevention of Bax and Bad in mitochondria dysfunction in GBM. In addition, miR-26a expression levels negatively correlate with Bax, Bad levels, and GBM progression; but highly correlate with HIF-1α levels in clinical cancer tissues. These findings provide a new link in the mechanistic understanding of TMZ resistance under glioma hypoxia microenvironment, and consequently HIF-1α/miR-26a/Bax/Bad signaling pathway as a promising adjuvant therapy for GBM with TMZ.Keywords
Funding Information
- National Natural Science Foundation of China (81772951, 81302182, 81472944, 81320108019, 81502170)
- National Institutes of Health (R01ES020868, R01CA193511)
- American Cancer Society (RSG NEC-129306)
This publication has 40 references indexed in Scilit:
- Bortezomib overcomes MGMT-related resistance of glioblastoma cell lines to temozolomide in a schedule-dependent mannerInvestigational New Drugs, 2013
- A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1Journal of Molecular Cell Biology, 2012
- From tumor hypoxia to cancer progression: the implications of hypoxia-inducible factor-1 expression in cancersAnatomy & Cell Biology, 2012
- MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesisNucleic Acids Research, 2011
- MiR-21 Induced Angiogenesis through AKT and ERK Activation and HIF-1α ExpressionPLOS ONE, 2011
- H2AX phosphorylation screen of cells from radiosensitive cancer patients reveals a novel DNA double-strand break repair cellular phenotypeBritish Journal of Cancer, 2010
- The Hypoxia-Inducible Factor 1/NOR-1 Axis Regulates the Survival Response of Endothelial Cells to HypoxiaMolecular and Cellular Biology, 2009
- Temozolomide- and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DSBs, and p53British Journal of Cancer, 2009
- Apoptosis in health and disease and modulation of apoptosis for therapy: An overviewIndian Journal of Clinical Biochemistry, 2007
- Bcl-XL and Calyculin A Prevent Translocation of Bax to Mitochondria during ApoptosisBiochemical and Biophysical Research Communications, 2002